Adaptimmune Therapeutics PLC
NASDAQ:ADAP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Adaptimmune Therapeutics PLC
NASDAQ:ADAP
|
UK |
Shareholder Yield
Current shareholder yield for
ADAP is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
Peers Comparison
Shareholder Yield
Price Appreciation
ADAP Price
Adaptimmune Therapeutics PLC
| Average Annual Return | -45.72% |
| Standard Deviation of Annual Returns | 19.79% |
| Max Drawdown | -99% |
| Market Capitalization | 580k USD |
| Shares Outstanding | 16 111 111 |
| Percentage of Shares Shorted | 14.34% |